Inhibition of Lipopolysaccharide-Induced Interleukin 8 in Human Adenocarcinoma Cell Line HT-29 by Spore Probiotics: B. Coagulans and B. Subtilis (natto)
Overview
Affiliations
Probiotics are used as a treatment for different intestinal disorders. They confer health benefits by different ways. This study was aimed to investigate immunomodulatory effect of Bacillus probiotic spores on the production of lipopolysaccharide (LPS)-induced interleukin 8 (IL-8) in HT-29 intestinal epithelial cells. Differentiated intestinal epithelial cell line was used as a model for the study of colonization of purified spores (Bacillus subtilis (natto) and B. coagulans) and their anti-inflammatory effects. MTT assay and trypan blue staining were used for the detection of optimal concentration of the purified spores and LPS. Pre-treatment assay was done by treatment of the cells with the purified spores for 2 h, followed by challenges with LPS for 3 and 18 h. Post-treatment assay was done by initial treatment of the cells with LPS for 18 h, followed by the spores for 3 and 6 h. Levels of IL-8 secretion and its mRNA expression were measured by ELISA and relative Q real-time PCR. Our results showed similar rates of adherence to intestinal epithelial cells by the spore probiotics, while displaying no cytotoxic effect. In the pre-treatment assay, a significant decrease in IL-8, at both protein and mRNA levels, was measured for B. coagulans spores after the addition of LPS, which was higher than those observed for Bacillus subtilis (natto) spores. In the post-treatment assay, while Bacillus subtilis (but not B. coagulans) diminished the LPS-stimulated IL-8 levels after 3 h of incubation, the inhibitory effect was not constant. In conclusion, ability of Bacillus spore probiotics for adherence to intestinal epithelial cell and their anti-inflammatory effects, through interference with LPS/IL-8 signaling, was shown in this study. Further studies are needed to characterize responsible bacterial compounds associated with these effects.
Elkhichi P, Aslanimehr M, Javadi A, Yadegar A Iran J Microbiol. 2024; 16(4):434-442.
PMID: 39267934 PMC: 11389770. DOI: 10.18502/ijm.v16i4.16301.
Li J, Yang M, Chen B, Wang Z, Cao Y, Yang Y Microorganisms. 2024; 12(3).
PMID: 38543490 PMC: 10972176. DOI: 10.3390/microorganisms12030439.
Natto: A medicinal and edible food with health function.
Wang C, Chen J, Tian W, Han Y, Xu X, Ren T Chin Herb Med. 2023; 15(3):349-359.
PMID: 37538862 PMC: 10394349. DOI: 10.1016/j.chmed.2023.02.005.
H S R, Halami P Probiotics Antimicrob Proteins. 2021; 15(2):351-362.
PMID: 34581975 DOI: 10.1007/s12602-021-09851-y.
Rohith H, Halami P Arch Microbiol. 2021; 203(6):2989-2998.
PMID: 33772601 DOI: 10.1007/s00203-021-02257-y.